Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation

Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation

Cytokine-induced killer (CIK) cells are advanced therapy medicinal products, so their production and freezing process has to be validated before their clinical use, to verify their stability as a drug formulation according to the good manufacturing practice (GMP) guidelines. We designed a stability...

Full description

Bibliographic Details
Main Authors: Katia Mareschi, Aloe Adamini, Sara Castiglia, Deborah Rustichelli, Laura Castello, Alessandra Mandese, Marco Leone, Giuseppe Pinnetta, Giulia Mesiano, Ivana Ferrero, Franca Fagioli
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Pharmaceuticals
Subjects:
advanced therapy medicinal product (ATMP)
good manufacturing practice (GMP)
cytokine-induced killer (CIK) cells
cryopreservation
drug formulation
stability program
Online Access:https://www.mdpi.com/1424-8247/13/5/93

Internet

https://www.mdpi.com/1424-8247/13/5/93

Similar Items